Bowman Consulting Group Ltd.BWMNNASDAQ

52-Week Range20-46

20.24Current 27.0645.83

Want to monitor BWMN?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

No description available.

Professional, Scientific, and Technical Services

Administrative Management and General Management Consulting Services

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

FutureGen Industries Announces Open Market Investments

Kevin Warsh promised to overhaul the Federal Reserve and cut rates. He is being greeted by rising inflation, an oil shock and a confirmation in limbo.

ZYXIQ DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

ROSEN, A LEADING LAW FIRM, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT

AMD's Real Shift Is Still Mispriced

Nvidia Trades at 21 Times Forward Earnings. Is the World's Biggest Artificial Intelligence (AI) Stock Actually a Value Play?

3 High-Yield Stocks That Could Help Set You Up for Life

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

FIVN Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Five9, Inc. - FIVN

Bonds Decoupling From Oil Amid Longer Conflict Fears

HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China

Super Micro: Ignore Bad Optics

Navitas Semiconductor Is Flashy. This Boring AI Stock Might Make You More Money.

ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

Gold Edges Lower on Prospects of Liquidity-Driven Sales

Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENPH

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE

About